Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

3 treatments under study, led by Secondary Nirdhi Scan When A Planned Repeat Ct Is Performed

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 2 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

1Total
Not Applicable (1)

Trial Status

Completed1
Not Yet Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (2)

Showing 2 of 2 trials
NCT07338383Not Yet Recruiting

Efficacy and Feasibility Trial of a Portable Near Infra-Red Hematoma Imager (NIRD-HI)

NCT03483727Not ApplicableCompletedPrimary

Use of a Hand-held Digital Cognitive Aid in the Early Management of Simulated War Wounds.

Showing all 2 trials

Research Network

Common Treatments

  • Secondary Nirdhi Scan When A Planned Repeat Ct Is Performed1
  • Nirdhi Scan At The Time Of Enrollment1
  • Simmaxmarcheryan1

Active Sponsors

  • Claude Bernard University1
  • The Geneva Foundation1
  • Congressionally Directed Medical Research Programs1
  • Uniformed Services University of the Health Sciences1

Top Investigators

Related Conditions

  • Traumatic Brain Injury1
  • Point Of Care1
  • Intracranial Hemorrhages1

Activity Timeline